Evaluation of Sleep-EEG in Transgenic Mice

2017

PsychoGenics will carry out EEG readings of sleeping and awake ACE1 transgenic mice containing genetic variants identified by Genome-Wide Association Studies (GWAS) for their impact on Alzheimer’s disease risk. This research is being conducted in conjunction with Robert Vassar, Ph.D.’s project “Molecular and Cellular Mechanisms of ACE1 Variant in Alzheimer’s Disease.”

PsychoGenics Studies of Alternative Neurodegenerative Pathways Translational

Senescent Cells and Alzheimer’s Disease

Jeffrey Savas, | 2018

The Role of Impaired Synaptic Vesicle Machinery Proteostasis in Alzheimer’s Disease Pathogenesis

Erik S. Musiek, | 2018

The Circadian Clock Modulates Neurodegeneration in Alzheimer’s Disease Via REV-ERBA (Year 1)

Geraldine J. Kress, | 2018

Central Clock Influence on Alzheimer’s Disease Pathogenesis

Elizabeth R. Sharlow, George S. Bloom, John S. Lazo, | 2017

Targeting Cell Cycle Re-entry Using 3-D Neuron Cultures

Paula Grammas, | 2017

Cerebrovascular Dysfunction in AD: Targeting the Mechanisms of Vascular Activation

PsychoGenics, | 2017

Evaluation of Sleep-EEG in Transgenic Mice

Karen Duff, Tal Nuriel, | 2016

Investigating the Mechanism of Entorhinal Cortex Hypermetabolism in APOE4 Targeted Replacement Mice

Evaluation of Sleep-EEG in Transgenic Mice

Funding to Date

Focus

Researchers

Related Content:

Senescent Cells and Alzheimer’s Disease

The Role of Impaired Synaptic Vesicle Machinery Proteostasis in Alzheimer’s Disease Pathogenesis

The Circadian Clock Modulates Neurodegeneration in Alzheimer’s Disease Via REV-ERBA (Year 1)

Central Clock Influence on Alzheimer’s Disease Pathogenesis

Targeting Cell Cycle Re-entry Using 3-D Neuron Cultures

Cerebrovascular Dysfunction in AD: Targeting the Mechanisms of Vascular Activation

Evaluation of Sleep-EEG in Transgenic Mice

Investigating the Mechanism of Entorhinal Cortex Hypermetabolism in APOE4 Targeted Replacement Mice